|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
價值評估 |
盈利(現時/預測)
-1.63/-3.74
|
企業價值
147.45M
|
資產負債 |
每股賬面淨值
4.80
|
現金流量 |
現金流量率
--
|
損益表 |
收益
51.13M
|
每股收益
0.01
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
報價延遲最少15分鐘:2024/10/31 19:21 EDT
同行比較之報價最少15分鐘延遲
業務概覽
|
|||
Repare Therapeutics Inc is a precision medicine oncology company focused on the development of synthetic lethality-based therapies for patients with cancer. The Company's focus is the research, development and commercialization of precision oncology drugs targeting specific vulnerabilities of tumors in genetically defined patient populations. The company derives maximum revenue from Canada. |